Marksans Pharma
MARKSANS.NS
$2.03
Share price
-1.74%
Change (1 day)
107.14%
Change (1 year)
Categories
Marksans Pharma (MARKSANS.NS) - P/B ratio
P/B ratio as of April 2024 : 4.02
According to Marksans Pharma
's latest financial reports the company has a price-to-book ratio of 4.02.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Marksans Pharma - P/B ratio (from 2012 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.79 | 110.76% |
| 2022-12-31 | 1.80 | -18.48% |
| 2021-12-31 | 2.20 | -33.6% |
| 2020-12-31 | 3.32 | 194.08% |
| 2019-12-31 | 1.13 | -49.47% |
| 2018-12-31 | 2.23 | -35.6% |
| 2017-12-31 | 3.47 | -2.54% |
| 2016-12-31 | 3.56 | -62.34% |
| 2015-12-31 | 9.45 | -12.28% |
| 2014-12-31 | 10.8 | 86.78% |
| 2013-12-31 | 5.77 | -1731.78% |
| 2012-12-31 | -0.3535 |